Bioefficacy of EPA–DHA from lipids recovered from fish processing wastes through biotechnological approaches.

The effect of fish oil recovered from fish visceral waste (FVW-FO) on serum and liver lipids, activity of
HMG-CoA reductase in liver microsomes and EPA + DHA incorporation in liver, heart and brain were evaluated.
Rats were fed different concentrations of FVW-FO providing 1.25%, 2.50%, 5.0% EPA + DHA recovered
by either fermentation or enzymatic hydrolysis for 8 weeks. Feeding FVW-FO reduce triacylglycerols
(5.96–20.3%), total cholesterol (7.9–21.5%) and LDL (7.39–21.7%) cholesterol levels in serum compared to
group fed on a control diet (groundnut oil). The activity of HMG-CoA reductase was reduced (p < 0.05) in
the FVW-FO fed groups compared to the control. EPA + DHA level in serum, liver, brain and heart
increased with increments in dietary EPA + DHA. Results show the hypolipidemic property of FVW-FO
and reduced HMG-CoA reductase activity which is proportional to the incorporation of EPA + DHA.
Recovery of FVW-FO will address the increasing demand for fish oil and reduce pollution problems.